Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA)

NCT04675814 | Completed Results

• 1 other identifier: ICO-2020-05
• Study Type: observational
• Target: 37
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this study is to evaluate the effects of regular physical practice on fatigue, quality of life and kinesiophobia in patients treated at the ICO in Angers, regardless of the type of cancer and the type of treatment.

Conditions

Sports Physical Therapy

Keywords

Adapted Physical Activity program (APA); kinesiophobia; Fatigue; Quality of life

Outcome Measures

Primary Outcomes (1)

• Quality of Life of Patients Participating in the 12-week Adapted Physical Activity Program.

  Describe the evolution of the quality of life of patients being treated for their cancer pathology at the ICO site in Angers, and participating in the 12-week adapted physical activity program at ICO. Quality of life is measured with the FACIT-F Fatigue and Quality of Life Questionnaire. The questionnaire is structured into five sections, each containing between 6 and 13 items. In total, it includes 40 items, each scored from 0 to 4: 0 - Not at all 1. \- A little 2. \- Moderately 3. \- Quite a bit 4. \- Very much By adding up the answers, the score range obtained is: 0 to 160. The higher the score, the less tired the patient is.

  12 weeks

Secondary Outcomes (3)

• Describe Attendance at the APA Program.

  12 weeks

• Measure the Evolution of Kinesiophobia (Fear of Movement).

  12 weeks

• Measure Physical Activity at the Initiation of the APA Program.

  Week 0

Interventions

Adapted Physical Activity (APA) OTHER

Adults participating in the APA program at ICO during the first semester of 2020, regardless of cancer type and ongoing treatment (chemotherapy, radiotherapy, hormone therapy, immunotherapy). The APA program duration is : 12 weeks

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Subjects participating in the ICO's APA program during the enrolment period regardless of the type of cancer and the type of treatment in progress (chemotherapy, radiotherapy, hormone therapy, immunotherapy) who accept to participate to the study.

You may qualify if:

• Oncological care at the ICO
• All types of cancer
• Regardless of the type of treatment (chemotherapy, radiotherapy, hormone therapy, immunotherapy)
• Age \> 18 years old
• Follow the APA program at the ICO
• Subject informed of the study

You may not qualify if:

• Contraindication to the practice of sport
• APA Program outside the ICO
• Subject opposing the use of his data
• Minor or adult patient under guardianship or curatorship
• Pregnant woman
• Altered general condition

Sponsors & Collaborators

• Institut Cancerologie de l'Ouest: lead

Study Sites (1)

Institut de Cancérologie de L'Ouest

Angers, 49055, France

Location

MeSH Terms

Conditions

Kinesiophobia; Fatigue

Condition Hierarchy (Ancestors)

Phobic Disorders; Anxiety Disorders; Mental Disorders; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Results Point of Contact

• Title: Dr ABADIE-LACOURTOISIE Sophie
• Organization: Institut de Cancérologie de l'Ouest

Sophie.Abadie-Lacourtoisie@ico.unicancer.fr

+33 2 41 35 27 00

Study Officials

• Sophie ABADIE-LACOURTOISIE, MD

  Institut de Cancérologie de l'Ouest

  STUDY CHAIR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 1, 2020
• First Posted: December 19, 2020
• Study Start: September 14, 2020
• Primary Completion: March 14, 2021
• Study Completion: March 14, 2021
• Last Updated: January 27, 2026
• Results First Posted: January 27, 2026

Record last verified: 2021-05

Locations

FR (1)